Related Experiment Videos
[Radionuclide cardangiography as non-invasive assessment in coronary heart disease (author's transl)]
Insights
Radionuclide cardangiography (RNCA), specifically the first bolus pass method (FBP), accurately assesses left ventricular function in coronary heart disease (CHD). FBP provides high-quality, non-invasive data crucial for diagnosing and managing conditions like acute myocardial infarction (AMI).
Area of Science:
- Cardiology
- Nuclear Medicine
- Diagnostic Imaging
Background:
- Coronary heart disease (CHD) necessitates accurate non-invasive assessment methods.
- Left ventricular function parameters like ejection fraction (EF) and wall motion (WM) are critical for CHD evaluation.
- Radionuclide cardangiography (RNCA) is an established non-invasive technique for assessing cardiac function.
Purpose of the Study:
- To evaluate the efficacy of radionuclide cardangiography (RNCA), particularly the first bolus pass method (FBP).
- To determine the diagnostic value of FBP in assessing left ventricular function in patients with coronary heart disease (CHD).
- To compare the information quality of FBP with other non-invasive methods in acute myocardial infarction (AMI).
Main Methods:
- Utilized radionuclide cardangiography (RNCA) with the first bolus pass (FBP) technique.
- Employed a multicrystal gamma camera for enhanced imaging capabilities.
- Analyzed ejection fraction (EF), wall motion (WM), stroke volume (SV), and their distributions.
Main Results:
- RNCA, especially FBP, precisely determines key left ventricular function parameters (EF, WM, SV).
- FBP effectively separates right and left heart activity, enabling distribution analysis.
- Specific RNCA findings correlate with angina pectoris, acute myocardial infarction (AMI), and heart failure, showing reversibility with nitrates for angina but not for AMI/heart failure.
Conclusions:
- The first bolus pass (FBP) method of radionuclide cardangiography (RNCA) is highly effective for assessing left ventricular function in coronary heart disease (CHD).
- FBP offers superior, non-invasive diagnostic information, particularly in the early stages of acute myocardial infarction (AMI).
- This technique is classified as very useful and effective in clinical cardiology practice.
Abstract:
The method of radionuclide cardangiography (RNCA) has become a well-established method amongst non-invasive assessments in coronary heart disease (CHD). By means of RNCA the most important parameters of left ventricular function, viz. ejection fraction (EF) and wall motion (WM), can be determined very exactly. The first bolus pass method (FBP), which allows satisfactory separation between right and left heart, enables the additional determination of EF distribution, stroke volume (SV) and SV distribution. This method requires the technical necessity of a multicrystal gamma camera. Special nuclear medicine characteristics have been worked out for different groups of CHD. EF and WM show typical signs of angina pectoris, caused by exercise correlating with reduced perfusion in the referring section of WM. While these changes may be reversible after nitrate administration, pathological myocardial function caused by acute myocardial infarction (AMI) or manifest heart failure is not reversed by nitroglycerine. Typical findings were seen in the course of AMI: initial decrease in global EF and diffuse (multilocated) asynergies in the left ventricular wall; in the second week possible start of recovery, including regression of dyskinesia to akinesia at the end of hospitalization. Especially in the early phase of AMI it was demonstrated that FBP--as a non-invasive technique--gives high information quality which is unequalled by other comparable methods. Therefore, the described method of FBP should be classified as very useful and effective in clinical cardiology.